참고문헌
- Azuma, M., Sato, H., Oue, Y., Okabe, K., Ota, T., Tsuchimoto, M. and Kiyoki, M. (1995): Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models. Bone, 16, 215-245 https://doi.org/10.1016/8756-3282(94)00032-U
- Behrens, B. and Karber, G. (1935): Wie sind Rehenversuche fur biologische Ausvertungen am zweckmasigsten anzuordnen? Naunyn-Schmiedeberg's Archiv Experimentelle Pathologie und Pharmacologie, 177, 379-388
- Boonekamp, P.M., Van der Wee-Pals, L.J.A., Van Wijk-Van Lennep, M.M.L., Thesingh, C.W. and Bijvoet, O.L.M. (1986): Two modes of action of bisphosphonate on osteoclastic resorption of mineralized matrix. Bone Min., 1, 27-39
- Caniggia, A., Nuti, R. and Martini, G. et al. 1996: Efficacy and safety of long-term, open-label treatment with calcitriol in postmenopausal osteoporosis: a retrospective analysis. Curr. Ther. Res. Clin. Exp., 57, 857-869
- Canigga, A. and Vattimo, A. (1979): Effects of 1,25-dihydroxycholecalciferol on calcium absorption in post-menopausal osteoporosis. Clin. Endocrinol., 11, 99-103
- Carano, A., Teitelbaum, S.L., Konsek, J.D., Schlesinger, P.H. and Blair, H.C. (1990): Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J. Clin. Invest., 85, 456-461 https://doi.org/10.1172/JCI114459
- Fawcett, J. (1999): Physician's drug handbook 8th ed., Springhouse Corp., Springhouse, Pennsylvania, 149-150
- Frediani, B. Allegri, A., Bisgono, S. and Marcolongo, R. (1998): Effect of combined treatment of calcitriol plus alendronate on bone mass and bone turnover in postmenopausal osteoporosis two years of contineous treatment. Clinical Drug Invest., 5, 235-244
- Gallagher, J.C. (1990): Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis. Metabolism, 39 Suppl.1, 27-29
- Inveresk Research International (1979): Standard Operating Procedures in Toxicology (Paget, G.E. and Thomson, R. eds.), MTP press, Lancaster, England
- James, E.F. and Reynolds, M. (1993): The Extra Pharmacopoeia (30th edition), The Pharmaceutical Press, London
- Korea Food and Drug Administration (1999): Guidelines for Toxicity Testing of Pharmaceuticals, Public Notice No.1999-61
- Kiriyama, T., Okamoto, S., Suzuki, H., Nagata, A., Izumi, M., Morii, H. and Nagatagi, S. (1989): Biological activity of 26, 26, 26, 27, 27, 27-hexa-fluoro-1, 25-dihydroxyvitamin D3 in the chick. Acta. Endoclinologica, 121, 520-524
- Lowik, C.W.G.M., Van der Pluijm, G., Van der Wee-pals, L.J.A., Bloys-Van Treslong-de Groot, H. and Bijvoet, O.L.M. (1988): Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts. J. Bone Min. Res., 3, 185-192
- Malavolta, N., Zanardi, M., Veronesi, M., Ripamonti, C. and Gnudi, S. (1999): Calcitriol and alendronate combination treatment in menopausal women with low bone mass. Int. J. Tissue React., 21, 51-9
- Nagao, Y., Ishitobi, Y., Fukushima, S., awashima, H. and Kumagawa, M. (1990): Ym-175 inhibits osteoclast differentiation and bone resorbingaction of mature osteoclasts. J. Bone Min. Res., 5, S159
- Nakatsuka, K., Imanishi, Y., Morishima, Y., Sekiya, K., Sasao, K., Miki, T., Nishizawa, Y., Katsumata, T., Nagata, A., Murakawa, S. and Mori, H. (1992): Biological potency of a fluorinated vitamin D analogue in hypoparathyroidism. Bone and Mineral, 16, 73-81 https://doi.org/10.1016/0169-6009(92)90823-V
- Need, A.G., Horowitz, M., Philcox, J.C. and Nordin, B.E. (1985): 1,25-dihydroxycholecalciferol and calcium therapy in osteoporosis with calcium malabsorption. Miner. Electrolyte Metab., 11, 35-40
- Sahni, M., Guenther, H.L., Fleisch, H., Collin, P. and Martin, T.J. (1993): Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J. Clin. Invest., 91, 2004-2011 https://doi.org/10.1172/JCI116422
- Wendlova, J., Galbavy, S. and Paukovic, J. (1999): Paget's disease of bone--treatment with alendronate, calcium and calcitriol. Vnitr. Lek., 45, 602-605